What a GLP-1 doctor reviews before prescribing

A GLP-1 doctor is a prescriber, not a brand ambassador

The search 'GLP-1 doctor' means someone with a license, a formulary they understand, and the spine to say no. It does not mean a celebrity. It does not mean a chatbot that always approves. Incretin medicines have contraindications. A clinician who never finds one is not thorough.

This page is educational. Beema's treatment pages are where you start intake. Here we list what a careful review looks like so Houston, Texas, and nationwide searches all land on the same clinical bar.

The history checklist behind a yes or no

Labeled obesity products commonly exclude people with a personal or family history of medullary thyroid carcinoma or MEN 2 because of rodent C-cell findings and the boxed warning. Prior pancreatitis, severe gastrointestinal disease, pregnancy, and certain diabetic retinopathy situations change the conversation. Kidney function, gallbladder history, and mental-health context also belong in the chart.

Medication lists matter. Insulin and sulfonylureas raise hypoglycemia risk if an incretin is added for someone with diabetes. Oral drugs with a narrow therapeutic index can be affected by delayed gastric emptying. Your job is to list everything, including supplements such as berberine.

BMI is a screen, not a moral score

Many labels use BMI 30, or 27 with a comorbidity, as a starting frame. Clinicians still look at the whole person. A number on a calculator does not create a right to a prescription. Beema's BMI tool on treatment pages is educational, not an approval engine.

The job continues after the first prescription

Nausea peaks during titration. A doctor who disappears after the first shipment is not offering a program. Follow-up should catch dehydration, inadequate protein, hair shedding from rapid loss, and the urge to jump doses. It should also catch success that lets you discuss maintenance.

How Beema's clinicians fit

Beema Health does not claim every patient sees the same named doctor. Independent licensed providers review intake. Compounded semaglutide or compounded tirzepatide may be prescribed when legally available and clinically appropriate. Compounded semaglutide is not FDA-approved. Compounded tirzepatide is not FDA-approved. Cash-pay rates on the medication pages cover visits, medicine, supplies, and expedited shipping without a membership fee.

If you want a local Houston endocrinologist for complex type 1 diabetes or post-bariatric anatomy, say so and use in-person care for those problems even if you also explore telehealth for weight management. Programs can complement each other when communication is honest.

Questions to ask any GLP-1 clinician

Ask which license they hold and in which state. Ask which pharmacy fills. Ask what they do if you are not a candidate. Ask how after-hours severe abdominal pain is handled (answer: emergency department, not a portal message). If you like Beema's answers, use /semaglutide or /tirzepatide to begin. A prescription is never guaranteed.

• Contraindication review before any pen
• No guaranteed approval
• Follow-up for GI effects and nutrition

Frequently asked questions

Sources

1. [1] Wegovy (semaglutide) prescribing information: contraindications include MTC and MEN 2; warnings include pancreatitis and gallbladder disease.
2. [2] Zepbound (tirzepatide) U.S. prescribing information, Eli Lilly (dual agonist labeling, similar class warnings).
3. [3] NIDDK. Who might be a candidate for prescription obesity medications.
4. [4] Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity. Diabetes, Obesity and Metabolism. 2021.